article Open AccessTop 1% cited
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Ophthalmology · 2016 · Vol. 123(6) · pp. 1386–1394
Michael F. Marmor✉(Stanford University)Ulrich Kellner(Textilforschungsinstitut Thüringen-Vogtland)Timothy Y. Y. Lai(Chinese University of Hong Kong)Ronald B. Melles(Kaiser Permanente Redwood City Medical Center)William F. Mieler(University of Illinois Chicago)
Drug-Induced Ocular ToxicitySystemic Lupus Erythematosus ResearchRetinal Diseases and TreatmentsMedicineHydroxychloroquineMaculopathyRetinopathyFundus (uterus)OphthalmologyChloroquineInternal medicineDiseasePathology
MeSH terms
Academies and InstitutesAdultChloroquineElectroretinographyFemaleFluorescein AngiographyHumansHydroxychloroquineMaximum Allowable ConcentrationMiddle AgedOphthalmologyRetinal DiseasesRisk FactorsUnited StatesVision Disorders
Citations
1,143
FWCI
87.30
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Cited by
Risk-Based screening and imaging strategies for hydroxychloroquine retinopathy: A prospective analysis from southern India
International Journal of Medical Ophthalmology · 2021 · 0 citations
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · 803 citations
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Annals of the Rheumatic Diseases · 2020 · 788 citations
References
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
Ophthalmology · 2011 · 684 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.